1. 1238TiPA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. (23rd October 2018) Authors: Jabulowsky, R A; Loquai, C; Derhovanessian, E; Mitzel-Rink, H; Utikal, J; Hassel, J; Kaufmann, R; Pinter, A; Diken, M; Gold, M; Heesen, L; Schreeb, K H; Schwarck-Kokarakis, D; Kreiter, S; Gaiser, M R; Jäger, D; Grabbe, S; Türeci, Ö; Sahin, U Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Admission lactate level and the GRACE 2.0 score are independent and additive predictors of 30-day mortality of STEMI patients treated with primary PCI - preliminary results of a real-world registry. (26th April 2021) Authors: Szabo, D; Szabo, A; Kugler, S; Pinter, A; Juhasz, V; Ruppert, M; Olah, A; Edes, IF; Becker, D; Merkely, B; Hizoh, I Journal: European heart journal Issue: Volume 10(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1167Effect of diabetes on all-cause mortality in CRT patients. (18th June 2020) Authors: Merkel, E D; Behon, A; Schwertner, W R; Pinter, A; Osztheimer, I; Geller, L; Zima, E; Becker, D P; Kosztin, A; Merkely, B Journal: Europace Issue: Volume 22(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The benefits of adding a defibrillator to cardiac resynchronization therapy - Systematic review and meta-analysis. (19th May 2022) Authors: Veres, B; Schwertner, WR; Engh, M; Masszi, R; Kuthi, L; Behon, A; Merkel, ED; Osztheimer, I; Fehervari, P; Ghare, S; Pinter, A; Zima, E; Hegyi, P; Kosztin, A; Merkely, B Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The effect of implantable cardioverter defibrillator in patients with cardiac resynchronizational therapy and diabetes mellitus. (19th May 2022) Authors: Masszi, R; Merkel, E; Schwertner, W; Veres, B; Behon, A; Pinter, A; Osztheimer, I; Zima, E; Geller, L; Becker, D; Kosztin, A; Merkely, B Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗